🇺🇸 FDA
Patent

US 7122558

Quinuclidine derivatives and medicinal compositions containing the same

granted A61PA61P1/00A61P1/04

Quick answer

US patent 7122558 (Quinuclidine derivatives and medicinal compositions containing the same) held by Almirall Prodesfarma S.A. expires Mon Oct 12 2026 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Almirall Prodesfarma S.A.
Grant date
Tue Oct 17 2006 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Oct 12 2026 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
24
CPC classes
A61P, A61P1/00, A61P1/04, A61P11/00, A61P13/00